Keeping you up to date on recent developments in orthopedics, including: Magnetic field and hydrogels could be used to grow new cartilage; COVID-19 pandemic has dramatic impact on osteoporosis management, finds new global study; Casting call: Why immobilizing helps in healing; Osteoarthritis biomarker could help 300 million people worldwide.
Keeping you up to date on recent developments in orthopedics, including: Light stimulation makes bones heavier; NCCN: New research finds low bone health testing rates after prostate cancer treatment; A diet high in prunes prevents bone loss associated with spinal cord injuries.
Keeping you up to date on recent developments in orthopedics, including: LED-based UV irradiation safely prevents the loss of bone and muscle mass in mice; Coupling antibiotics with stem cells to fight off bone infections; Study: Unnecessary stress testing performed prior to knee and hip replacement surgeries.
Keeping you up to date on recent developments in orthopedics, including: SCS reduces pain and motor symptoms in PD patients; Is rheumatoid arthritis two different diseases?; Lockdown impact: Worsening symptoms for people with bone, joint and muscle pain.
Keeping you up to date on recent developments in orthopedics, including: Technology for printing customized neuroprostheses on a 3D bioprinter; AI could expand healing with bioscaffolds; AI detects osteoarthritis years before it develops; 'Bandage' developed to rebuild broken bone.
Keeping you up to date on recent developments in orthopedics, including: Restless nature of human spinal cord revealed by noninvasive functional imaging; Stronger bones thanks to heat and microbiota; Researchers use soy to improve bone cancer treatment.
Portable dialysis machine manufacturer Outset Medical Inc. saw its shares soar after the opening of its Nasdaq IPO. The stock rose as high as $61.60 before closing at $60.68, finishing the day with a market cap of nearly $2.5 billion. Trading under the ticker symbol OM, the company priced 8.95 million of its shares at $27 apiece, upsizing its previously reported plans to offer 7.6 million shares between $22 and $24. The offering is set to close Sept. 17.
Keeping you up to date on recent developments in cardiology, including: SCAD vs. plaques in heart attacks; Gut microbiome data may be helpful in routine screening of cardiovascular disease; Some health care professionals use outdated guidelines to screen and diagnose hypertension.
Keeping you up to date on recent developments in orthopedics, including: New drug shown to improve bone growth in children with achondroplasia; Failure to calibrate for ethnicity in fracture epidemiology would do more harm than good; Muscle aging: Stronger for longer; After Medicaid expansion, 'unmet need' for joint replacement surgery.
Keeping you up to date on recent developments in orthopedics, including: Implant choice more important than surgeon skill for hip replacement success; Vertebral body tethering shows clinical success as treatment for scoliosis; Hip fracture risk linked to nanoscale bone inflexibility; Bioventus reports first use of its Signfuse bioactive bone graft in strip format.